Steven Moss
Founder at Isomerase Therapeutics Ltd.
Steven Moss active positions
| Companies | Position | Start | End |
|---|---|---|---|
Isomerase Therapeutics Ltd.
 Isomerase Therapeutics Ltd. BiotechnologyHealth Technology Isomerase Therapeutics Ltd. operates as a drug discovery and development company. It specializes in biosynthetic medicinal chemistry and synthetic biology, microbial natural products, microbial natural products, and semisynthetic chemistry. The company was founded by Barrie Wilkinson, Matthew Gregory, and Steven Moss in 2012 and is headquartered in Cambridge, the United Kingdom. | Chief Tech/Sci/R&D Officer | 31/12/2011 | - |
| Founder | 31/12/2011 | - |
Career history of Steven Moss
Former positions of Steven Moss
| Companies | Position | Start | End |
|---|---|---|---|
Biotica Technology Ltd.
 Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB. | Corporate Officer/Principal | 04/01/2010 | 11/03/2013 |
Training of Steven Moss
| University of Durham | Doctorate Degree |
Statistics
International
| United Kingdom | 4 |
Operational
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
Biotica Technology Ltd.
Biotica Technology Ltd. Pharmaceuticals: MajorHealth Technology Biotica Technology Ltd. develops and manufactures pharmaceutical products. The company focuses on the discovery and development of novel therapeutics derived from polyketide through the targeted alteration of polyketide biosynthetic pathways. The firm was founded in 1996 by Peter Leadlay and Jim Staunton and is headquartered in Saffron Walden, GB. | Health Technology |
Isomerase Therapeutics Ltd.
Isomerase Therapeutics Ltd. BiotechnologyHealth Technology Isomerase Therapeutics Ltd. operates as a drug discovery and development company. It specializes in biosynthetic medicinal chemistry and synthetic biology, microbial natural products, microbial natural products, and semisynthetic chemistry. The company was founded by Barrie Wilkinson, Matthew Gregory, and Steven Moss in 2012 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
- Stock Market
- Insiders
- Steven Moss
- Experience
